CN110669031A - Total synthesis method of natural product isoperidone J - Google Patents
Total synthesis method of natural product isoperidone J Download PDFInfo
- Publication number
- CN110669031A CN110669031A CN201911170969.2A CN201911170969A CN110669031A CN 110669031 A CN110669031 A CN 110669031A CN 201911170969 A CN201911170969 A CN 201911170969A CN 110669031 A CN110669031 A CN 110669031A
- Authority
- CN
- China
- Prior art keywords
- isobenzofuran
- methoxy
- reaction
- acid
- iodo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000006257 total synthesis reaction Methods 0.000 title claims abstract description 19
- 229930014626 natural product Natural products 0.000 title abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 73
- CONSJSAOECUWLV-UHFFFAOYSA-N methyl 3,5-dihydroxy-4-iodobenzoate Chemical compound COC(=O)C1=CC(O)=C(I)C(O)=C1 CONSJSAOECUWLV-UHFFFAOYSA-N 0.000 claims abstract description 12
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 claims abstract description 9
- 238000010511 deprotection reaction Methods 0.000 claims abstract description 8
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000003547 Friedel-Crafts alkylation reaction Methods 0.000 claims abstract description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 6
- 238000006619 Stille reaction Methods 0.000 claims abstract description 5
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims abstract description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 42
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- ILZNMTBMMRDVEO-UHFFFAOYSA-N methyl 3-hydroxy-4-iodo-5-methoxybenzoate Chemical compound OC=1C=C(C(=O)OC)C=C(C=1I)OC ILZNMTBMMRDVEO-UHFFFAOYSA-N 0.000 claims description 20
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- 239000003054 catalyst Substances 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 16
- 229910052763 palladium Inorganic materials 0.000 claims description 15
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 14
- 229960000583 acetic acid Drugs 0.000 claims description 13
- LRHJTBMDVOGRFX-UHFFFAOYSA-N 5-iodo-6-methoxy-4-(methoxymethoxy)-3H-2-benzofuran-1-one Chemical compound IC=1C(=C2COC(C2=CC=1OC)=O)OCOC LRHJTBMDVOGRFX-UHFFFAOYSA-N 0.000 claims description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 11
- LYLIMRJHFDMIEA-UHFFFAOYSA-N 4-hydroxy-5-iodo-6-methoxy-3H-2-benzofuran-1-one Chemical compound OC1=C2COC(C2=CC(=C1I)OC)=O LYLIMRJHFDMIEA-UHFFFAOYSA-N 0.000 claims description 10
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 8
- 239000012362 glacial acetic acid Substances 0.000 claims description 8
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 7
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 7
- 239000003377 acid catalyst Substances 0.000 claims description 7
- -1 halomethyl methyl ether Chemical compound 0.000 claims description 7
- 229920002866 paraformaldehyde Polymers 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- JAMFGQBENKSWOF-UHFFFAOYSA-N bromo(methoxy)methane Chemical compound COCBr JAMFGQBENKSWOF-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 claims description 5
- 239000003880 polar aprotic solvent Substances 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical group COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 claims description 2
- 229940061627 chloromethyl methyl ether Drugs 0.000 claims description 2
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical group COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 125000005489 p-toluenesulfonic acid group Chemical group 0.000 claims description 2
- 238000007273 lactonization reaction Methods 0.000 claims 2
- 239000012022 methylating agents Substances 0.000 claims 2
- 150000001348 alkyl chlorides Chemical class 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 claims 1
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 abstract description 11
- 239000002994 raw material Substances 0.000 abstract description 11
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 5
- 150000002148 esters Chemical group 0.000 abstract description 2
- 238000007069 methylation reaction Methods 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000012074 organic phase Substances 0.000 description 33
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 238000010791 quenching Methods 0.000 description 14
- 239000007788 liquid Substances 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- 150000002576 ketones Chemical class 0.000 description 9
- 230000000717 retained effect Effects 0.000 description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 description 6
- 239000007810 chemical reaction solvent Substances 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- 240000000588 Hericium erinaceus Species 0.000 description 5
- 235000007328 Hericium erinaceus Nutrition 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- NTIBMIIYTKPBNR-UHFFFAOYSA-N methoxymethyl 2-hydroxybenzoate Chemical compound COCOC(=O)C1=CC=CC=C1O NTIBMIIYTKPBNR-UHFFFAOYSA-N 0.000 description 4
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 230000001035 methylating effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 150000007529 inorganic bases Chemical group 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- XCVNDBIXFPGMIW-UHFFFAOYSA-N n-ethylpropan-1-amine Chemical compound CCCNCC XCVNDBIXFPGMIW-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical class [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- AAXHHISTDMILPL-VXLYETTFSA-N 5-[(2E)-3,7-dimethyl-5-oxoocta-2,6-dienyl]-4-hydroxy-6-methoxy-2-(2-phenylethyl)-3H-isoindol-1-one Chemical compound C1C=2C(O)=C(C\C=C(/C)CC(=O)C=C(C)C)C(OC)=CC=2C(=O)N1CCC1=CC=CC=C1 AAXHHISTDMILPL-VXLYETTFSA-N 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IDSCVDJWBRGNKG-LFYBBSHMSA-N Hericenone A Chemical compound OC1=C(C\C=C(/C)CC(=O)C=C(C)C)C(OC)=CC2=C1COC2=O IDSCVDJWBRGNKG-LFYBBSHMSA-N 0.000 description 1
- 241000123222 Hericium Species 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LSOHVISLXBAOJE-UHFFFAOYSA-N hericenone-A Natural products COc1cc2C(=C)OCc2c(O)c1CC=C(/C)CC(=O)C=C(C)C LSOHVISLXBAOJE-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000009251 neurologic dysfunction Effects 0.000 description 1
- 208000015015 neurological dysfunction Diseases 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种异苯并呋喃酮类天然化合物,具体涉及一种异猴头菌酮J的全合成方法,属于天然产物合成技术领域。The invention relates to an isobenzofuranone class natural compound, in particular to a total synthesis method of isohericium ketone J, and belongs to the technical field of natural product synthesis.
背景技术Background technique
猴头菌作为一种药食兼用菌,性平味甘,入胃经,有助于消化,利五脏,扶正固本,具有健脑提神的功效。相关提取的多糖类化合物、脂肪酸、二萜类化合物、生物碱、甾醇类化合物和异猴头菌酮J(Isohericenone J)、猴头菌酮A(Hericenone)等芳香化合物在治疗消化道疾病、神经功能障碍、糖尿病、肿瘤等方面引起了人们的广泛关注。Hericium erinaceus, as a medicinal and edible fungus, is mild in nature and sweet in taste. Related extracted polysaccharides, fatty acids, diterpenoids, alkaloids, sterols and aromatic compounds such as Isohericenone J and Hericenone A are used in the treatment of digestive tract diseases, Neurological dysfunction, diabetes, tumors, etc. have aroused widespread concern.
异猴头菌酮J,是从猴头菇中分离出来的一种异苯并呋喃酮衍生物,结构式如下:Hericium erinone J, is a kind of isobenzofuranone derivative isolated from Hericium erinaceus, the structural formula is as follows:
2015年由Kim小组确定结构,而且Kim小组研究发现这类化合物表现出明显的抑制急性髓细胞白血病HL-60和HEL-299的细胞活性(Food Chem.,2015,170,336-342)。The structure was determined by Kim's group in 2015, and Kim's group's research found that this type of compound showed significant inhibition of acute myeloid leukemia HL-60 and HEL-299 cellular activity (Food Chem., 2015, 170, 336-342).
然而,由于结构中相对复杂,全合成研究很少,限制了该类异苯并呋喃酮类化合物在药物开发中的进一步应用。However, due to the relative complexity in the structure, there are few studies on total synthesis, which limits the further application of this class of isobenzofuranones in drug development.
发明内容SUMMARY OF THE INVENTION
为了克服上述技术缺陷,本发明提供了一种异苯并呋喃酮类天然化合物,尤其是异猴头菌酮J的全合成方法。以商业可得3,5-二羟基-4-碘苯甲酸甲酯1为起始原料,经过甲基化反应、傅克烷基化和酯交换连锁反应,合成异苯并呋喃酮中间体3;中间体3羟基经过保护后,接着被制成锡试剂中间体5;随后中间体5与乙酸香叶酯经过Stille偶联后,脱保护生成异猴头菌酮J。In order to overcome the above-mentioned technical defects, the present invention provides a method for the total synthesis of isobenzofuranone natural compounds, especially isohericium ketone J. Using commercially available methyl 3,5-dihydroxy-4-iodobenzoate 1 as the starting material, through methylation reaction, Friedel-Crafts alkylation and transesterification chain reaction, isobenzofuranone intermediate 3 was synthesized; After the hydroxyl group of body 3 is protected, it is then made into tin reagent intermediate 5; then intermediate 5 is coupled with geranyl acetate through Stille, and then deprotected to generate isoericin J.
本发明所述异猴头菌酮J的全合成方法,从3,5-二羟基-4-碘苯甲酸甲酯出发,依次经过单甲基化、傅克烷基化/内酯化、羟基保护、催化锡基化、Stille偶联、脱保护等六步反应后完成,采用反应方程式表示如下:The total synthesis method of isohericin J according to the present invention starts from methyl 3,5-dihydroxy-4-iodobenzoate, and goes through successively monomethylation, Friedel-Crafts alkylation/lactonation, hydroxyl protection, Catalytic tinylation, Stille coupling, deprotection and other six-step reactions are completed, and the reaction equation is expressed as follows:
在上述反应中,具体包括以下步骤:In the above reaction, the following steps are specifically included:
第一步、单甲基化:The first step, monomethylation:
将3,5-二羟基-4-碘苯甲酸甲酯(1)、碱和在极性非质子溶剂中反应,得到3-羟基-4-碘-5-甲氧基苯甲酸甲酯(2)。Reaction of methyl 3,5-dihydroxy-4-iodobenzoate (1), a base and in a polar aprotic solvent affords methyl 3-hydroxy-4-iodo-5-methoxybenzoate (2 ).
其中,甲基化试剂选自碳酸二甲酯、硫酸二甲酯、碘甲烷等。碱选自无机碱(如碳酸钾、碳酸钠、碳酸铯等)或有机碱(如三乙胺、二异丙基乙胺等),优选碳酸钾或碳酸铯。极性非质子溶剂选自DMF、DMSO、二氧六环等。Wherein, the methylating reagent is selected from dimethyl carbonate, dimethyl sulfate, methyl iodide and the like. The base is selected from inorganic bases (such as potassium carbonate, sodium carbonate, cesium carbonate, etc.) or organic bases (such as triethylamine, diisopropylethylamine, etc.), preferably potassium carbonate or cesium carbonate. The polar aprotic solvent is selected from DMF, DMSO, dioxane and the like.
进一步地,在上述反应条件下,所述3,5-二羟基-4-碘苯甲酸甲酯1、甲基化试剂与碱摩尔比为1:0.8-1.5:1-3;优选摩尔比为1:1-1.2:1.5-2。Further, under the above reaction conditions, the molar ratio of the methyl 3,5-dihydroxy-4-iodobenzoate 1, the methylating reagent and the base is 1:0.8-1.5:1-3; the preferred molar ratio is 1:1-1.2:1.5-2.
本步典型操作如下:向反应釜中依次加入3,5-二羟基-4-碘苯甲酸甲酯1、碱和极性非质子溶剂,滴加甲基化试剂,室温反应;反应完成后加氯化铵饱和溶液淬灭,萃取分液,有机层经水洗干燥后,脱溶浓缩,加入醚类和烷烃溶剂结晶纯化,得到3-羟基-4-碘-5-甲氧基苯甲酸甲酯2。The typical operation of this step is as follows: add methyl 3,5-dihydroxy-4-iodobenzoate 1, alkali and polar aprotic solvent to the reaction kettle in turn, add methylating reagent dropwise, and react at room temperature; after the reaction is completed, add Quenched with saturated ammonium chloride solution, extracted and separated, the organic layer was washed and dried with water, then desolvated and concentrated, added ether and alkane solvent for crystallization and purification to obtain methyl 3-hydroxy-4-iodo-5-methoxybenzoate 2.
第二步、傅克烷基化/内酯化:The second step, Friedel-Crafts alkylation/lactonation:
将3-羟基-4-碘-5-甲氧基苯甲酸甲酯(2)和多聚甲醛在混合酸存在下反应生成4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮(3)。Reaction of methyl 3-hydroxy-4-iodo-5-methoxybenzoate (2) and paraformaldehyde in the presence of mixed acid to generate 4-hydroxy-5-iodo-6-methoxy-3H-isophenyl and furan-1-one (3).
其中,混合酸为冰醋酸和氢溴酸混合物,其中冰乙酸为溶剂。该反应在傅克反应结束后,自发进行酯交换形成内酯。Wherein, the mixed acid is a mixture of glacial acetic acid and hydrobromic acid, wherein glacial acetic acid is a solvent. After the Friedel-Crafts reaction, the reaction spontaneously undergoes transesterification to form lactones.
进一步地,在上述反应条件下,所述3-羟基-4-碘-5-甲氧基苯甲酸甲酯2、多聚甲醛与氢溴酸摩尔比为1:0.8-2:1-3;优选摩尔比为1:2:1.1。Further, under the above reaction conditions, the molar ratio of the methyl 3-hydroxy-4-iodo-5-methoxybenzoate 2, paraformaldehyde and hydrobromic acid is 1:0.8-2:1-3; The preferred molar ratio is 1:2:1.1.
本步典型操作如下:向反应釜中依次加入3-羟基-4-碘-5-甲氧基苯甲酸甲酯2、多聚甲醛和冰醋酸,0℃滴加氢溴酸和冰醋酸混合液,滴加完成后室温反应;反应完成后加饱和碳酸氢钠溶液淬灭,萃取分液,有机层经水洗干燥后,脱溶浓缩,加入醚类和烷烃混合溶剂结晶纯化,得到4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮3。The typical operation of this step is as follows: add methyl 3-hydroxy-4-iodo-5-methoxybenzoate 2, paraformaldehyde and glacial acetic acid successively to the reaction kettle, and dropwise add a mixed solution of hydrobromic acid and glacial acetic acid at 0°C , after the dropwise addition was completed, the reaction was carried out at room temperature; after the reaction was completed, a saturated sodium bicarbonate solution was added to quench, and the liquid was extracted and separated. 5-iodo-6-methoxy-3H-isobenzofuran-1-one 3.
第三步、羟基保护:The third step, hydroxyl protection:
将4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮(3)、碱和卤甲基甲醚在氯代烷烃溶剂中反应生成5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮(4)。4-Hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1-one (3), base and halomethyl methyl ether were reacted in a chlorinated alkane solvent to give 5-iodo-6- Methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one (4).
其中,碱选自无机碱(例如碳酸钾、碳酸钠、碳酸铯)或有机碱(如三乙胺、二异丙基乙胺等),优选二异丙基乙胺。卤甲基甲醚选自氯甲基甲醚或溴甲基甲醚。氯代烷烃溶剂选自二氯甲烷、1,2-二氯乙烷,氯仿等,优选二氯甲烷。Wherein, the base is selected from inorganic bases (such as potassium carbonate, sodium carbonate, cesium carbonate) or organic bases (such as triethylamine, diisopropylethylamine, etc.), preferably diisopropylethylamine. The halomethyl methyl ether is selected from chloromethyl methyl ether or bromomethyl methyl ether. The chlorinated alkane solvent is selected from dichloromethane, 1,2-dichloroethane, chloroform, etc., preferably dichloromethane.
进一步地,在上述反应条件下,4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮3、卤甲基甲醚与碱摩尔比为1:1-3:1-3;优选摩尔比为1:1.5:2。Further, under the above reaction conditions, the molar ratio of 4-hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1-one 3, halomethyl methyl ether and alkali is 1:1-3 : 1-3; the preferred molar ratio is 1:1.5:2.
本步典型操作如下:向反应釜中依次加入4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮3、碱和氯代烷烃溶剂,在0℃下滴加溴甲基甲醚,滴加完成后室温反应;反应完成后加水淬灭,萃取分液,有机层经水洗干燥后,脱溶浓缩,加入醚类和烷烃混合溶剂结晶纯化,得到5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮4。The typical operation of this step is as follows: successively add 4-hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1-one 3, alkali and chlorinated alkane solvent to the reactor, dropwise at 0 °C Add bromomethyl methyl ether, and react at room temperature after the dropwise addition is completed; after the reaction is completed, add water to quench, extract and separate the organic layer, wash and dry the organic layer, remove and concentrate, add ether and alkane mixed solvent for crystallization and purification to obtain 5-iodine -6-Methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one 4.
第四步、催化锡基化:The fourth step, catalytic tin-based:
将5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮(4)、钯催化剂和六甲基锡在溶剂中反应生成6-甲氧基-4-甲氧甲氧基-5-三甲基锡-3H-异苯并呋喃-1-酮(5)。5-Iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one (4), palladium catalyst and hexamethyltin were reacted in solvent to form 6-methoxy -4-Methoxymethoxy-5-trimethyltin-3H-isobenzofuran-1-one (5).
其中,所述钯催化剂选自Pd(PPh3)4、Pd2(dba)3或Pd(t-Bu3P)2中至少一种。反应溶剂选自甲苯、二氧六环、DMF或THF等常用溶剂。Wherein, the palladium catalyst is selected from at least one of Pd(PPh 3 ) 4 , Pd 2 (dba) 3 or Pd(t-Bu 3 P) 2 . The reaction solvent is selected from common solvents such as toluene, dioxane, DMF or THF.
进一步地,在上述反应条件下,5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮4、钯催化剂与六甲基锡摩尔比为1:0.001-0.020:1-3;优选摩尔比为1:0.05-0.10:1.2-1.5。Further, under above-mentioned reaction conditions, 5-iodo-6-methoxyl group-4-methoxymethoxyl group-3H-isobenzofuran-1-one 4, palladium catalyst and hexamethyltin mol ratio are 1 : 0.001-0.020: 1-3; the preferred molar ratio is 1: 0.05-0.10: 1.2-1.5.
本步典型操作如下:向反应釜中依次加入5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮4、钯催化剂和六甲基锡和反应溶剂,氮气保护下回流反应;反应完成后加水淬灭,萃取分液,有机层经水洗干燥后,脱溶浓缩,加入烷烃溶剂结晶纯化,得到6-甲氧基-4-甲氧甲氧基-5-三甲基锡-3H-异苯并呋喃-1-酮5。The typical operation of this step is as follows: 5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one 4, palladium catalyst and hexamethyltin and The reaction solvent is refluxed under the protection of nitrogen; after the reaction is completed, water is added to quench, extract and liquid separation, the organic layer is washed and dried with water, then desolvated and concentrated, and an alkane solvent is added for crystallization and purification to obtain 6-methoxy-4-methoxymethoxy yl-5-trimethyltin-3H-isobenzofuran-1-one 5.
第五步、Stille偶联:The fifth step, Stille coupling:
将6-甲氧基-4-甲氧甲氧基-5-三甲基锡-3H-异苯并呋喃-1-酮(5)、钯催化剂乙酸香叶酯(6)和氯化锂在溶剂中反应生成MOM保护异猴头菌酮J(7)。6-Methoxy-4-methoxymethoxy-5-trimethyltin-3H-isobenzofuran-1-one (5), palladium catalyst geranyl acetate (6) and lithium chloride The reaction in the solvent generates MOM-protected ericin J(7).
其中,所述钯催化剂选自Pd2(dba)3、Pd(PPh3)4和Pd(t-Bu3P)2中的至少一种。反应溶剂选自甲苯、二氧六环、DMF和THF等常用溶剂。Wherein, the palladium catalyst is selected from at least one of Pd 2 (dba) 3 , Pd(PPh 3 ) 4 and Pd(t-Bu 3 P) 2 . The reaction solvent is selected from common solvents such as toluene, dioxane, DMF and THF.
进一步优选:第四步和第五步连续进行时,第五步无需钯催化剂;Further preferably: when the 4th step and the 5th step are carried out continuously, the 5th step does not need a palladium catalyst;
进一步地,在上述反应条件下,6-甲氧基-4-甲氧甲氧基-5-三甲基锡-3H-异苯并呋喃-1-酮5、钯催化剂、乙酸香叶酯6和氯化锂的摩尔比为1:0.001-0.02:1-3:1-3,优选摩尔比1:0.05-0.10:1.1-1.5:1-1.5。Further, under the above reaction conditions, 6-methoxy-4-methoxymethoxy-5-trimethyltin-3H-isobenzofuran-1-one 5, palladium catalyst, geranyl acetate 6 The molar ratio with lithium chloride is 1:0.001-0.02:1-3:1-3, preferably the molar ratio is 1:0.05-0.10:1.1-1.5:1-1.5.
本步典型操作如下:向反应釜中依次加入6-甲氧基-4-甲氧甲氧基-5-三甲基锡-3H-异苯并呋喃-1-酮5、钯催化剂、乙酸香叶酯6、氯化锂和反应溶剂,氮气保护下加热反应;反应完成后加水淬灭,萃取分液,有机层经水洗干燥后,脱溶浓缩,硅胶柱层析,得到MOM保护异猴头菌酮J-7。The typical operation of this step is as follows: successively add 6-methoxy-4-methoxymethoxy-5-trimethyltin-3H-isobenzofuran-1-one 5, palladium catalyst, acetic acid into the reactor Leaf ester 6, lithium chloride and reaction solvent were heated and reacted under the protection of nitrogen; after the reaction was completed, water was added to quench, extract and liquid separation, the organic layer was washed and dried, desolvated and concentrated, and subjected to silica gel column chromatography to obtain MOM-protected Hericium erinaceus Mycoketone J-7.
第六步、脱保护:The sixth step, deprotection:
将MOM保护异猴头菌酮J(7)在酸催化剂存在下脱保护后得到异猴头菌酮J。Deprotection of MOM-protected ericin J (7) in the presence of an acid catalyst yields ericin J.
其中,所述酸催化剂选自对甲基苯磺酸、樟脑磺酸和醋酸等,优选樟脑磺酸。所述反应溶剂选自甲醇、乙醇和异丙醇等常用醇类溶剂。Wherein, the acid catalyst is selected from p-toluenesulfonic acid, camphorsulfonic acid, acetic acid, etc., preferably camphorsulfonic acid. The reaction solvent is selected from common alcohol solvents such as methanol, ethanol and isopropanol.
进一步地,在上述反应条件下,MOM保护异猴头菌酮J-7与酸催化剂摩尔比为1:1-3;优选摩尔比为1:2-2.5。Further, under the above reaction conditions, the molar ratio of MOM-protected isohericin J-7 to the acid catalyst is 1:1-3; the preferred molar ratio is 1:2-2.5.
本步典型操作如下:向反应釜中依次加入MOM保护异猴头菌酮J-7、酸催化剂和反应溶剂,混合物室温搅拌反应;反应完成后加三乙胺淬灭,萃取分液,有机层经水洗干燥后,脱溶浓缩,产物混合物经反相中压柱层析法分离得到异猴头菌酮J。The typical operation of this step is as follows: add MOM-protected isohericium ketone J-7, acid catalyst and reaction solvent to the reaction kettle in turn, and the mixture is stirred at room temperature for reaction; after the reaction is completed, add triethylamine to quench, extract and separate liquids, and the organic layer After washing and drying, desolventizing and concentrating, the product mixture was separated by reversed-phase medium pressure column chromatography to obtain isohericium ketone J.
发明有益效果Invention Beneficial Effects
本发明首次提供了异猴头菌酮J的全合成方法,本合成方法原料简单易得,反应过程中各单元反应条件温和可控,反应收率较高。在天然产物全合成和药物发现中具有重要的应用价值。The present invention provides a total synthesis method of isohericium ketone J for the first time. The synthesis method has simple and easy-to-obtain raw materials, mild and controllable reaction conditions of each unit in the reaction process, and high reaction yield. It has important application value in the total synthesis of natural products and drug discovery.
具体实施方式Detailed ways
下述结合具体实施例对本发明的技术方案做进一步详细的说明。The technical solutions of the present invention will be described in further detail below with reference to specific embodiments.
实施例1Example 1
1)3-羟基-4-碘-5-甲氧基苯甲酸甲酯2的合成,具体过程如下:1) the synthesis of 3-hydroxy-4-iodo-5-methoxybenzoic acid methyl ester 2, concrete process is as follows:
向干燥1L四口瓶中依次投入3,5-二羟基-4-碘苯甲酸甲酯29.4g(0.1mol,99%),碳酸钾27.6g(0.2mol,98%,2eq)和200g DMF,室温下缓慢滴加碘甲烷17.03g(0.12mol,99%,1.2eq.),滴加完毕后室温下搅拌反应24h,TLC检测,反应原料3,5-二羟基-4-碘苯甲酸甲酯转化完全。29.4g (0.1mol, 99%) of methyl 3,5-dihydroxy-4-iodobenzoate, 27.6g (0.2mol, 98%, 2eq) of potassium carbonate and 200g DMF were successively put into a dry 1L four-necked flask, 17.03 g of methyl iodide (0.12 mol, 99%, 1.2 eq.) was slowly added dropwise at room temperature. After the addition was completed, the reaction was stirred at room temperature for 24 h. TLC detected the reaction raw material, methyl 3,5-dihydroxy-4-iodobenzoate. complete conversion.
反应完毕,降至室温,加入饱和氯化铵溶液500g淬灭反应,搅拌0.5h,加入乙酸乙酯萃取分层,保留有机相;有机相用2*250g水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到淡黄色粘稠液体,加入异丙醚和正己烷重结晶,得到白色固体19.1g,为目标中间体2,3-羟基-4-碘-5-甲氧基苯甲酸甲酯,收率62.0%。After the reaction was completed, it was lowered to room temperature, 500 g of saturated ammonium chloride solution was added to quench the reaction, stirred for 0.5 h, ethyl acetate was added to extract the layers, and the organic phase was retained; the organic phase was washed twice with 2*250 g of water; anhydrous sulfuric acid was added to the organic phase Sodium was dried, filtered and concentrated; a light yellow viscous liquid was obtained, which was recrystallized by adding isopropyl ether and n-hexane to obtain 19.1 g of a white solid, which was the target intermediate 2,3-hydroxy-4-iodo-5-methoxybenzene Methyl formate, yield 62.0%.
熔点128-130℃;1H NMR(400MHz,CD3OD):7.13-7.11(m,1H),7.03-6.99(m,1H),3.88(s,6H).13C NMR(100MHz,CD3OD):168.1,161.2,159.6,132.8,109.4,103.4,83.3,57.0,52.8.HRMS-ESI(m/z):calcd for C9H8IO4(M-H)-306.9473,found 306.9476.Melting point 128-130℃; 1H NMR(400MHz, CD 3 OD): 7.13-7.11(m, 1H), 7.03-6.99(m, 1H), 3.88(s, 6H). 13 C NMR(100MHz, CD 3 OD) ): 168.1, 161.2, 159.6, 132.8, 109.4, 103.4, 83.3, 57.0, 52.8. HRMS-ESI(m/z): calcd for C 9 H 8 IO 4 (MH) - 306.9473, found 306.9476.
2)4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮3的合成,具体过程如下:2) the synthesis of 4-hydroxyl-5-iodo-6-methoxyl group-3H-isobenzofuran-1-one 3, the concrete process is as follows:
向干燥250mL四口瓶中依次投入中间体2(3-羟基-4-碘-5-甲氧基苯甲酸甲酯)15.4g(0.05mol,99%)、多聚甲醛3.0g(0.1mol,98%,2eq)和100g冰醋酸,降温至0℃,缓慢滴加氢溴酸18.4g溶液(0.075mol,33%醋酸溶液,1.5eq),滴加完毕后室温下搅拌反应24h,TLC检测,反应原料3-羟基-4-碘-5-甲氧基苯甲酸甲酯转化完全。Into a dry 250mL four-necked flask, successively put into intermediate 2 (methyl 3-hydroxy-4-iodo-5-methoxybenzoate) 15.4g (0.05mol, 99%), paraformaldehyde 3.0g (0.1mol, 98%, 2eq) and 100g glacial acetic acid, cooled to 0°C, slowly added dropwise 18.4g of hydrobromic acid solution (0.075mol, 33% acetic acid solution, 1.5eq), after the addition was completed, the reaction was stirred at room temperature for 24h, TLC detected, The reaction raw material 3-hydroxy-4-iodo-5-methoxybenzoic acid methyl ester was converted completely.
反应完毕,加入饱和碳酸氢钠溶液200g淬灭反应,加入乙酸乙酯萃取分层,保留有机相;有机相用2*50g饱和食盐水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到淡黄色固体,加入异丙醚和正己烷重结晶,得到白色固体11.2g,为目标中间体3,4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮,收率73.2%。After the reaction was completed, 200 g of saturated sodium bicarbonate solution was added to quench the reaction, ethyl acetate was added to extract the layers, and the organic phase was retained; the organic phase was washed twice with 2*50 g of saturated brine; the organic phase was dried by adding anhydrous sodium sulfate, filtered, and concentrated. to obtain a light yellow solid, which was recrystallized by adding isopropyl ether and n-hexane to obtain 11.2 g of a white solid, which was the target intermediate 3,4-hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1 -ketone, yield 73.2%.
熔点180-182℃,1H NMR(400MHz,CDCl3):6.89(s,1H),5.89(s,1H),5.27(s,2H),3.96(s,3H).13C NMR(100MHz,CDCl3):170.8,160.1,150.8,128.6,125.3,98.4,85.9,68.0,57.3.HRMS-ESI(m/z):calcd for C9H6IO4(M-H)-304.9316,found 304.9322.Melting point 180-182℃, 1 H NMR (400MHz, CDCl 3 ): 6.89(s, 1H), 5.89(s, 1H), 5.27(s, 2H), 3.96(s, 3H). 13 C NMR(100MHz, CDCl 3 ): 170.8, 160.1, 150.8, 128.6, 125.3, 98.4, 85.9, 68.0, 57.3. HRMS-ESI (m/z): calcd for C 9 H 6 IO 4 (MH) - 304.9316, found 304.9322.
3)5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮4的合成,具体过程如下:3) Synthesis of 5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one 4, the concrete process is as follows:
向干燥250mL四口瓶中依次投入中间体3(4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮)9.2g(0.03mol,98%)、二异丙基乙胺7.8g(0.06mol,99%,4eq)和100g二氯甲烷,降温至0℃,缓慢滴加溴甲基甲醚溶液28.1g(0.045mol,20%二氯甲烷溶液,1.5eq),滴加完毕后室温下搅拌反应24h,TLC检测,反应原料4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮转化完全。Into a dry 250mL four-necked flask, put intermediate 3 (4-hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1-one) 9.2g (0.03mol, 98%), diiso 7.8g of propylethylamine (0.06mol, 99%, 4eq) and 100g of dichloromethane, cooled to 0°C, slowly added dropwise 28.1g of bromomethyl methyl ether solution (0.045mol, 20% solution of dichloromethane, 1.5eq ), and the reaction was stirred at room temperature for 24 h after the dropwise addition. TLC detected that the reaction raw material 4-hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1-one was completely converted.
反应完毕,加入水100g淬灭反应,萃取分液,保留有机相;有机相用2*50g饱和食盐水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到黄色黏稠液体,加入异丙醚和正己烷重结晶,得到白色固体9.1g,为目标中间体4(5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮),收率86.2%。After the reaction was completed, 100 g of water was added to quench the reaction, extracted and separated, and the organic phase was retained; the organic phase was washed twice with 2*50 g of saturated brine; the organic phase was dried by adding anhydrous sodium sulfate, filtered, and concentrated; Recrystallization from propyl ether and n-hexane gave 9.1 g of white solid, which was the target intermediate 4 (5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one), Yield 86.2%.
熔点163-165℃,1H NMR(400MHz,CDCl3):7.07(s,1H),5.40(s,2H),5.17(s,2H),3.97(s,3H),3.58(s,3H).13C NMR(100MHz,CDCl3):170.6,160.8,152.7,128.7,101.4,97.6,91.7,77.4,68.6,57.4,57.3.HRMS-ESI(m/z):calcd for C11H12IO5(M+H)+350.9724,found350.9722.Melting point 163-165℃, 1 H NMR (400MHz, CDCl 3 ): 7.07(s, 1H), 5.40(s, 2H), 5.17(s, 2H), 3.97(s, 3H), 3.58(s, 3H) . 13 C NMR (100 MHz, CDCl 3 ): 170.6, 160.8, 152.7, 128.7, 101.4, 97.6, 91.7, 77.4, 68.6, 57.4, 57.3. HRMS-ESI (m/z): calcd for C 11 H 12 10 5 (M+H) + 350.9724,found350.9722.
4)6-甲氧基-4-甲氧甲氧基-5-三甲基锡-3H-异苯并呋喃-1-酮5的合成,具体过程如下:4) Synthesis of 6-methoxy-4-methoxymethoxy-5-trimethyltin-3H-isobenzofuran-1-ketone 5, the concrete process is as follows:
向干燥的250mL四口瓶中依次投入中间体4(5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮)8.8g(0.025mol,97%)、Pd(t-Bu3P)2催化剂0.64g(0.00125mol,99%,0.05eq),Sn(CH3)6 12.3g(0.0375mol,99%,1.0eq)和100g甲苯,氮气置换并在氮气保护下加热至100℃反应24h,TLC检测,反应原料5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮转化完全。Into a dry 250mL four-necked flask, put into the intermediate 4 (5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one) 8.8g (0.025mol, 97 %), Pd(t- Bu3P ) 2 catalyst 0.64g (0.00125mol, 99%, 0.05eq), Sn( CH3 ) 6 12.3g (0.0375mol, 99%, 1.0eq) and 100g toluene, nitrogen replacement And heated to 100 ℃ under nitrogen protection for 24 hours, TLC detection, the reaction raw material 5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one was completely converted.
反应完毕,加入水100g淬灭反应,萃取分液,保留有机相;有机相用2*50g饱和氟化钾的氨水溶液洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到淡黄色固体,加入异丙醚和正己烷重结晶,得到白色固体6.0g,为目标中间体5(6-甲氧基-4-甲氧甲氧基-5-三甲基锡-3H-异苯并呋喃-1-酮),收率61.5%。After the reaction is completed, add 100 g of water to quench the reaction, extract and separate, and retain the organic phase; the organic phase is washed twice with an aqueous ammonia solution of 2*50 g saturated potassium fluoride; the organic phase is dried by adding anhydrous sodium sulfate, filtered, and concentrated; The yellow solid was recrystallized by adding isopropyl ether and n-hexane to obtain 6.0 g of white solid, which was the target intermediate 5(6-methoxy-4-methoxymethoxy-5-trimethyltin-3H-isophenylene) and furan-1-one), yield 61.5%.
熔点93-94℃,1H NMR(400MHz,CDCl3):7.05(s,1H),5.38(s,2H),5.04(s,2H),3.82(s,3H),3.50(s,3H),0.33(s,9H).13C NMR(100MHz,CDCl3):171.3,166.1,156.9,130.3,129.4,127.0,100.5,96.2,69.6,56.8,55.9,-6.8.HRMS-ESI(m/z):calcd for C14H21O5Sn(M+H)+389.0406,found 389.0402.Melting point 93-94℃, 1 H NMR (400MHz, CDCl 3 ): 7.05(s, 1H), 5.38(s, 2H), 5.04(s, 2H), 3.82(s, 3H), 3.50(s, 3H) , 0.33(s, 9H). 13 C NMR (100MHz, CDCl 3 ): 171.3, 166.1, 156.9, 130.3, 129.4, 127.0, 100.5, 96.2, 69.6, 56.8, 55.9, -6.8.HRMS-ESI (m/z ):calcd for C 14 H 21 O 5 Sn(M+H) + 389.0406, found 389.0402.
5)MOM保护异猴头菌酮J-7的合成,具体过程如下:5) MOM protects the synthesis of heterohericin J-7, and the concrete process is as follows:
向干燥250mL四口瓶中依次投入6-甲氧基-4-甲氧甲氧基-5-三甲基锡-3H-异苯并呋喃-1-酮5.8g(0.015mol,97%)、乙酸香叶酯3.2g(0.0165mol,99%,1.1eq.)、Pd2(dba)3催化剂0.69g(0.75mmol,97%,0.05eq)、无水氯化锂0.7g(0.0165mol,99%,1.1eq.)和DMF50g,氮气置换三次并在氮气保护下加热至50℃反应24h。Into a dry 250mL four-necked flask, 5.8g (0.015mol, 97%) of 6-methoxy-4-methoxymethoxy-5-trimethyltin-3H-isobenzofuran-1-one, 5.8g (0.015mol, 97%), Geranyl acetate 3.2g (0.0165mol, 99%, 1.1eq.), Pd 2 (dba) 3 catalyst 0.69g (0.75mmol, 97%, 0.05eq), Anhydrous lithium chloride 0.7g (0.0165mol, 99 %, 1.1 eq.) and DMF 50g, replaced with nitrogen three times and heated to 50°C under nitrogen protection for 24h.
反应完毕,降至室温,加入冰水200g淬灭,搅拌0.5h,加入二氯甲烷萃取分液,保留有机相;有机相用2*50g饱和氟化钾的氨水溶液洗两次,再用2*50g盐水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到棕红色粘稠液体,硅胶柱层析,得到淡黄色油状液体3.1g,经核磁确认为MOM保护异猴头菌酮J-7,收率57.4%。After the reaction was completed, it was lowered to room temperature, quenched by adding 200 g of ice water, stirred for 0.5 h, and extracted with dichloromethane, and the organic phase was retained; the organic phase was washed twice with 2*50 g saturated potassium fluoride aqueous ammonia solution, *50g brine was washed twice; the organic phase was dried with anhydrous sodium sulfate, filtered, and concentrated; a brown-red viscous liquid was obtained, and silica gel column chromatography gave 3.1g of a light yellow oily liquid, which was confirmed by NMR as MOM-protected Hericium erinaceus Ketone J-7, yield 57.4%.
6)异猴头菌酮J的合成,具体过程如下:6) Synthesis of isohericium ketone J, the concrete process is as follows:
向干燥250mL四口瓶中依次投入MOM保护异猴头菌酮J-7(2.9g,0.008mol)、樟脑磺酸3.7g(0.016mol,99%,2.0eq)和甲醇50g,反应混合物在室温下反应24h,TLC检测脱保护转化完全。Into a dry 250mL four-necked flask, put MOM-protected ericine J-7 (2.9g, 0.008mol), 3.7g (0.016mol, 99%, 2.0eq) of camphorsulfonic acid and 50g of methanol in turn, and the reaction mixture was at room temperature The reaction was continued for 24 h, and the deprotection conversion was complete as detected by TLC.
反应完毕,加入三乙胺淬灭,搅拌0.5h,加入二氯甲烷和水萃取分液,保留有机相;有机相用2*50g盐水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到淡黄色粘稠液体,经硅胶柱层析将混合物中E:Z构型的比例由1.1:1左右提高到8:1,加入异丙醚和正己烷(1/5体积比)重结晶,得到E-构型的异猴头菌酮J,白色固体1.1g,收率44.6%。After the reaction is completed, add triethylamine to quench, stir for 0.5h, add dichloromethane and water to extract and separate, and retain the organic phase; the organic phase is washed twice with 2*50g brine; the organic phase is dried by adding anhydrous sodium sulfate, filtered, Concentrated; light yellow viscous liquid was obtained, the ratio of E:Z configuration in the mixture was increased from about 1.1:1 to 8:1 by silica gel column chromatography, isopropyl ether and n-hexane (1/5 volume ratio) were added to weigh Crystallized to obtain E-configuration ericin J, white solid 1.1 g, yield 44.6%.
熔点:95-97℃,1H NMR(400MHz,CDCl3):6.97(s,1H),6.04(s,1H),5.25(t,J=7.1Hz,1H),5.21(s,2H),5.03-4.99(m,1H),3.87(s,3H),3.48(d,J=7.1Hz,1H),2.17-2.07(m,4H),1.82(s,3H),1.67(s,3H),1.60(s,3H).13C NMR(100MHz,CDCl3):171.8,159.2,150.6,141.1,132.7,127.4,125.3,123.6,121.1,120.4,98.6,68.1,56.4,39.8,26.3,25.8,23.1,17.9,16.4.HRMS-ESI(m/z):calcd for C19H23O4(M+H)-315.1602,found315.1602.Melting point: 95-97°C, 1 H NMR (400MHz, CDCl 3 ): 6.97(s, 1H), 6.04(s, 1H), 5.25(t, J=7.1Hz, 1H), 5.21(s, 2H), 5.03-4.99(m, 1H), 3.87(s, 3H), 3.48(d, J=7.1Hz, 1H), 2.17-2.07(m, 4H), 1.82(s, 3H), 1.67(s, 3H) , 1.60(s, 3H). 13 C NMR (100 MHz, CDCl 3 ): 171.8, 159.2, 150.6, 141.1, 132.7, 127.4, 125.3, 123.6, 121.1, 120.4, 98.6, 68.1, 56.4, 39.8, 26.3, 25.8, 23.1, 17.9, 16.4. HRMS-ESI(m/z): calcd for C 19 H 23 O 4 (M+H) - 315.1602, found315.1602.
实施例2Example 2
1)3-羟基-4-碘-5-甲氧基苯甲酸甲酯2的合成,具体过程如下:1) the synthesis of 3-hydroxy-4-iodo-5-methoxybenzoic acid methyl ester 2, concrete process is as follows:
向干燥1L四口瓶中依次投入3,5-二羟基-4-碘苯甲酸甲酯29.4g(0.1mol,99%),碳酸钾27.6g(0.2mol,98%,2eq)和200g DMF,室温下缓慢滴加碘甲烷17.03g(0.12mol,99%,1.2eq),滴加完毕后室温下搅拌反应24h,TLC检测,反应原料3,5-二羟基-4-碘苯甲酸甲酯转化完全。29.4g (0.1mol, 99%) of methyl 3,5-dihydroxy-4-iodobenzoate, 27.6g (0.2mol, 98%, 2eq) of potassium carbonate and 200g DMF were successively put into a dry 1L four-necked flask, 17.03 g of methyl iodide (0.12 mol, 99%, 1.2 eq) was slowly added dropwise at room temperature. After the addition was completed, the reaction was stirred at room temperature for 24 h. TLC detected that the reaction raw material, methyl 3,5-dihydroxy-4-iodobenzoate, was converted into completely.
反应完毕,降至室温,加入饱和氯化铵溶液500g淬灭反应,搅拌0.5h,加入乙酸乙酯萃取分层,保留有机相;有机相用2*250g水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到淡黄色粘稠液体,加入异丙醚和正己烷重结晶,得到白色固体19.1g,为目标中间体2,3-羟基-4-碘-5-甲氧基苯甲酸甲酯,收率62.0%。After the reaction was completed, it was lowered to room temperature, 500 g of saturated ammonium chloride solution was added to quench the reaction, stirred for 0.5 h, ethyl acetate was added to extract the layers, and the organic phase was retained; the organic phase was washed twice with 2*250 g of water; anhydrous sulfuric acid was added to the organic phase Sodium was dried, filtered and concentrated; a light yellow viscous liquid was obtained, which was recrystallized by adding isopropyl ether and n-hexane to obtain 19.1 g of a white solid, which was the target intermediate 2,3-hydroxy-4-iodo-5-methoxybenzene Methyl formate, yield 62.0%.
2)4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮3的合成,具体过程如下:2) the synthesis of 4-hydroxyl-5-iodo-6-methoxyl group-3H-isobenzofuran-1-one 3, the concrete process is as follows:
向干燥250mL四口瓶中依次投入中间体2(3-羟基-4-碘-5-甲氧基苯甲酸甲酯)15.4g(0.05mol,99%)、多聚甲醛3.0g(0.1mol,98%,2eq)和100g冰醋酸,降温至0℃,缓慢滴加氢溴酸18.4g溶液(0.075mol,33%醋酸溶液,1.5eq),滴加完毕后室温下搅拌反应24h,TLC检测,反应原料3-羟基-4-碘-5-甲氧基苯甲酸甲酯转化完全。Into a dry 250mL four-necked flask, successively put into intermediate 2 (methyl 3-hydroxy-4-iodo-5-methoxybenzoate) 15.4g (0.05mol, 99%), paraformaldehyde 3.0g (0.1mol, 98%, 2eq) and 100g glacial acetic acid, cooled to 0°C, slowly added dropwise 18.4g of hydrobromic acid solution (0.075mol, 33% acetic acid solution, 1.5eq), after the addition was completed, the reaction was stirred at room temperature for 24h, TLC detected, The reaction raw material 3-hydroxy-4-iodo-5-methoxybenzoic acid methyl ester was converted completely.
反应完毕,加入饱和碳酸氢钠溶液200g淬灭反应,加入乙酸乙酯萃取分层,保留有机相;有机相用2*50g饱和食盐水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到淡黄色固体,加入异丙醚和正己烷重结晶,得到白色固体11.2g,为目标中间体3,4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮,收率73.2%。After the reaction was completed, 200 g of saturated sodium bicarbonate solution was added to quench the reaction, ethyl acetate was added to extract the layers, and the organic phase was retained; the organic phase was washed twice with 2*50 g of saturated brine; the organic phase was dried by adding anhydrous sodium sulfate, filtered, and concentrated. to obtain a light yellow solid, which was recrystallized by adding isopropyl ether and n-hexane to obtain 11.2 g of a white solid, which was the target intermediate 3,4-hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1 -ketone, yield 73.2%.
3)5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮4的合成,具体过程如下:3) Synthesis of 5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one 4, the concrete process is as follows:
向干燥250mL四口瓶中依次投入中间体3(4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮)9.2g(0.03mol,98%)、二异丙基乙胺7.8g(0.06mol,99%,4eq)和100g二氯甲烷,降温至0℃,缓慢滴加溴甲基甲醚溶液28.1g(0.045mol,20%二氯甲烷溶液,1.5eq),滴加完毕后室温下搅拌反应24h,TLC检测,反应原料4-羟基-5-碘-6-甲氧基-3H-异苯并呋喃-1-酮转化完全。Into a dry 250mL four-necked flask, put intermediate 3 (4-hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1-one) 9.2g (0.03mol, 98%), diiso 7.8g of propylethylamine (0.06mol, 99%, 4eq) and 100g of dichloromethane, cooled to 0°C, slowly added dropwise 28.1g of bromomethyl methyl ether solution (0.045mol, 20% solution of dichloromethane, 1.5eq ), and the reaction was stirred at room temperature for 24 h after the dropwise addition. TLC detected that the reaction raw material 4-hydroxy-5-iodo-6-methoxy-3H-isobenzofuran-1-one was completely converted.
反应完毕,加入水100g淬灭反应,萃取分液,保留有机相;有机相用2*50g饱和食盐水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到黄色黏稠液体,加入异丙醚和正己烷重结晶,得到白色固体9.1g,为目标中间体4(5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮),收率86.2%。After the reaction was completed, 100 g of water was added to quench the reaction, extracted and separated, and the organic phase was retained; the organic phase was washed twice with 2*50 g of saturated brine; the organic phase was dried by adding anhydrous sodium sulfate, filtered, and concentrated; Recrystallization from propyl ether and n-hexane gave 9.1 g of white solid, which was the target intermediate 4 (5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one), Yield 86.2%.
4)异猴头菌酮J的合成,具体过程如下:4) the synthesis of isohericium ketone J, the concrete process is as follows:
向干燥10mL三口瓶中依次投入中间体4(5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮)0.176g(0.5mmol,97%)、Pd(t-Bu3P)2催化剂0.0128g(0.025mmol,99%,0.05eq)、Sn(CH3)6 0.246g(0.75mmol,99%,1.0eq)和3g甲苯,氮气置换并在氮气保护下加热至100℃反应24h,TLC检测,反应原料5-碘-6-甲氧基-4-甲氧甲氧基-3H-异苯并呋喃-1-酮转化完全。Into a dry 10mL there-necked flask, successively put intermediate 4 (5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one) 0.176g (0.5mmol, 97%) , Pd(t-Bu 3 P) 2 catalyst 0.0128g (0.025mmol, 99%, 0.05eq), Sn(CH 3 ) 6 0.246g (0.75mmol, 99%, 1.0eq) and 3g toluene, replaced with nitrogen and replaced with nitrogen The reaction was heated to 100 °C for 24 h under nitrogen protection. TLC detection showed that the reaction raw material 5-iodo-6-methoxy-4-methoxymethoxy-3H-isobenzofuran-1-one was completely converted.
反应降温后,接着加入乙酸香叶酯0.107g(0.55mmol,99%,1.1eq)和无水氯化锂0.023g(0.55mmol,99%,1.1eq.),氮气置换并在氮气保护下加热至100℃反应24h。After the reaction was cooled down, geranyl acetate 0.107g (0.55mmol, 99%, 1.1eq) and anhydrous lithium chloride 0.023g (0.55mmol, 99%, 1.1eq.) were then added, replaced with nitrogen and heated under nitrogen protection Reaction at 100°C for 24h.
反应完毕,降至室温,加入冰水2g淬灭,搅拌0.5h,加入乙酸乙酯萃取分液,保留有机相;有机相用2*3g饱和氟化钾的氨水溶液洗两次,再用2*3g盐水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到棕红色粘稠液体,硅胶柱层析,得到淡黄色油状液体0.058g,经核磁确认为MOM保护异猴头菌酮J-7,收率32.6%。After the reaction was completed, it was lowered to room temperature, quenched by adding 2 g of ice water, stirred for 0.5 h, and extracted with ethyl acetate, and the organic phase was retained; the organic phase was washed twice with 2*3 g saturated potassium fluoride ammonia solution, and then 2 *3g brine was washed twice; the organic phase was dried with anhydrous sodium sulfate, filtered, and concentrated; a brown-red viscous liquid was obtained, and silica gel column chromatography gave 0.058g of a light yellow oily liquid, which was confirmed by NMR as MOM-protected Hericium erinaceus Ketone J-7, yield 32.6%.
接着向上述黄色油状液体中,加入樟脑磺酸(2.0eq)和甲醇10g,反应混合物在室温下反应24h,TLC检测脱保护转化完全。反应完毕,加入三乙胺淬灭,搅拌0.5h,加入二氯甲烷和水萃取分液,保留有机相;有机相用2*10g盐水洗两次;有机相加无水硫酸钠干燥、过滤、浓缩;得到淡黄色粘稠液体,经硅胶柱层析将混合物中E:Z构型的比例由约1.1:1左右提高到8:1,加入异丙醚和正己烷(1/5体积比)重结晶,得到E-构型异猴头菌酮J,收率45.5%。Then, to the above yellow oily liquid, camphorsulfonic acid (2.0 eq) and 10 g of methanol were added, the reaction mixture was reacted at room temperature for 24 h, and TLC detected that the deprotection conversion was complete. After the reaction is completed, add triethylamine to quench, stir for 0.5h, add dichloromethane and water to extract and separate, and keep the organic phase; the organic phase is washed twice with 2*10g brine; the organic phase is dried by adding anhydrous sodium sulfate, filtered, Concentrated; a pale yellow viscous liquid was obtained, and the ratio of E:Z configuration in the mixture was increased from about 1.1:1 to 8:1 by silica gel column chromatography, and isopropyl ether and n-hexane (1/5 volume ratio) were added. After recrystallization, the E-configuration isoericine J was obtained in a yield of 45.5%.
以上实施例描述了本发明的基本原理、主要特征和优点。本行业技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明原理的范围下,本发明还会有各种变化和改进,这些变化和改进均落入本发明保护的范围内。The above embodiments describe the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited by the above-mentioned embodiments, and the descriptions in the above-mentioned embodiments and the description are only to illustrate the principles of the present invention, and the present invention will have various changes without departing from the scope of the principles of the present invention. and improvements, these changes and improvements all fall within the scope of protection of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911170969.2A CN110669031B (en) | 2019-11-26 | 2019-11-26 | The total synthesis method of natural product isohericin J |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911170969.2A CN110669031B (en) | 2019-11-26 | 2019-11-26 | The total synthesis method of natural product isohericin J |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110669031A true CN110669031A (en) | 2020-01-10 |
CN110669031B CN110669031B (en) | 2021-04-16 |
Family
ID=69088166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911170969.2A Expired - Fee Related CN110669031B (en) | 2019-11-26 | 2019-11-26 | The total synthesis method of natural product isohericin J |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110669031B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104540826A (en) * | 2012-07-26 | 2015-04-22 | 默沙东公司 | Spiro-fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel |
-
2019
- 2019-11-26 CN CN201911170969.2A patent/CN110669031B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104540826A (en) * | 2012-07-26 | 2015-04-22 | 默沙东公司 | Spiro-fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel |
Non-Patent Citations (7)
Also Published As
Publication number | Publication date |
---|---|
CN110669031B (en) | 2021-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102653533B (en) | Total synthesis method of mangostin | |
CN111925381B (en) | A kind of synthetic method of baloxavir key intermediate | |
EP1147074A1 (en) | Synthesis method of nitroxymethylphenyl esters of aspirin derivatives | |
KR100346672B1 (en) | Method for preparing 3-O-substituted ascorbic acid | |
KR101269491B1 (en) | Preparation method for entecavir | |
CN109705094A (en) | A kind of preparation method of pyridine quinazoline | |
CN110256451A (en) | A kind of synthetic method of benzofuran simultaneously [2,3-b] quinoline | |
JPS584785A (en) | Manufacture of isosorbide-2-nitrate | |
CN110669031A (en) | Total synthesis method of natural product isoperidone J | |
JPH06166681A (en) | Quinic acid derivative and its preparation | |
JP4097291B2 (en) | Method for producing substituted valinamide derivative | |
Yamato et al. | Synthesis and antitumor activity of tropolone derivatives. 3 | |
JP2873599B2 (en) | Novel benzofuran derivative, uric acid excreting agent and method for producing the same | |
JP2005504019A (en) | Method for preparing isocoumarin | |
JPS5817186B2 (en) | Method for producing novel aromatic carboxylic acid derivatives | |
JPS5943946B2 (en) | N-alkenylmoranoline derivative | |
CN108203396B (en) | Synthesis of enkephalinase inhibitor | |
CN107936034B (en) | Benzyloxy dibenzo [b, f] dislikes English in heptan cyclopropylene acid compounds and intermediate and its application | |
CN108947953A (en) | A kind of synthetic method of flavone derivative | |
EP0240338B1 (en) | Butenoic acid derivatives | |
CN110627683A (en) | Preparation method of indanone intermediate | |
CA2782701A1 (en) | Combretastatin derivative preparation method | |
CN118290246B (en) | Method for preparing cynanchum bungei benzophenone | |
CN112552258B (en) | Thiazole amidoisomagnolanine derivatives, preparation method and application thereof | |
Li et al. | Practical and scalable synthesis of isosorbide derivatives containing an active amine group |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210416 Termination date: 20211126 |
|
CF01 | Termination of patent right due to non-payment of annual fee |